The bill
A resolution supporting the goals and ideals of "National Youth HIV/AIDS Awareness Day".
SRES. 171, 119th Congress — read as touching Pharmaceuticals.
Sponsored by
Sen. Blumenthal, Richard [D-CT]
ID: B001277
Follow the money
The bill
SRES. 171, 119th Congress — read as touching Pharmaceuticals.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
20 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Invalid Date
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Joy. Another meaningless resolution from the esteemed members of Congress, designed to make them feel good about themselves while accomplishing precisely nothing.
**Main Purpose & Objectives:** This resolution is a feel-good exercise in supporting "National Youth HIV/AIDS Awareness Day" and reaffirming the Senate's commitment to addressing the HIV epidemic among young people. The main objective is to look like they care, without actually doing anything meaningful.
**Key Provisions & Changes to Existing Law:** There are no actual provisions or changes to existing law in this resolution. It's a series of empty statements and platitudes, urging various stakeholders to "recognize and support" the day, "promote up-to-date information," and "support removal of HIV laws that are scientifically inaccurate." Wow, how brave.
**Affected Parties & Stakeholders:** The usual suspects: young people living with HIV, public health agencies, education agencies, schools, media organizations, and (of course) the pharmaceutical industry. Everyone gets a shout-out, but no actual help or resources are provided.
**Potential Impact & Implications:** Zero. Zilch. Nada. This resolution will not lead to any tangible changes in policy, funding, or outcomes for young people living with HIV. It's a PR stunt, designed to make the sponsors look good without actually doing anything to address the underlying issues.
Let me diagnose the real disease here: this resolution is a symptom of Congressional cowardice and incompetence. They're too afraid to tackle the actual problems – lack of funding, inadequate healthcare access, stigma, and discrimination – so they resort to empty gestures like this. It's a classic case of "legislative theater," where politicians pretend to care about an issue while doing nothing to actually address it.
And what's with the laundry list of "whereas" clauses? It's like they're trying to prove they've done their homework, but really, they're just regurgitating statistics and buzzwords. Newsflash: citing a bunch of numbers and acronyms doesn't make you look smart or informed; it makes you look like a lazy politician trying to cover your tracks.
In short, this resolution is a waste of time, paper, and taxpayer dollars. It's a cynical exercise in self-promotion, designed to make the sponsors feel good about themselves while ignoring the real needs of young people living with HIV.
Sen. Blumenthal, Richard [D-CT]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No organization contributions found
No committee contributions found
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 38 nodes and 20 connections (45 secondary connections hidden)
Total contributions: $54,100
Showing top 16 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 4 helped.
Resolution supports increasing funding for programs that support people impacted by HIV, including AIDS drug assistance programs and access to medications such as PrEP, post-exposure prophylaxis, and antiretroviral therapy (section (7)). This benefits pharmaceutical manufacturers of HIV treatments.
Resolution urges youth-friendly and accessible health care services, especially access to medications, and supports increasing funding for programs that support people impacted by HIV, including the Ryan White HIV/AIDS Program and Medicaid (sections (6) and (7)). This benefits hospitals and health systems providing HIV care.
Resolution notes that the Patient Protection and Affordable Care Act provides youth with better access to health care coverage, more health insurance options, additional funding for sex education, and expanded access to Medicaid, and prohibits denying people living with HIV access to health care (whereas clause). Supporting these provisions benefits health insurers by expanding coverage and enrollment.
Resolution supports increasing funding for programs that support people impacted by HIV, including AIDS drug assistance programs and access to medications such as PrEP (section (7)). Biotech firms developing HIV treatments and prevention (e.g., Moderna, Gilead) would benefit from increased funding and demand.